心血管

订阅

MedSci主页 / 所有栏目 / 心血管

Eur Heart J：R-ZES置入后早期中断DAPT与不良转归高风险相关

2014-02-19 高晓方 译 医学论坛网

R-ZES置入DAPT不良转归药物洗脱支架
关注

一项多国研究表明，在接受Resolute佐他莫司洗脱支架（R-ZES）置入的患者中，1个月内中断双重抗血小板治疗（DAPT）与不良转归高风险具有相关性；在1～12个月中断DAPT则与支架血栓形成（ST）和不良心血管转归低发生率有相关性。论文2月7日在线发表于《欧洲心脏杂志》（Eur Heart J）。此项研究共纳入4896例接受R-ZES置入的心梗患者，并评估DAPT中断与支架血栓形成（ST）和心

一项多国研究表明，在接受Resolute佐他莫司洗脱支架（R-ZES）置入的患者中，1个月内中断双重抗血小板治疗（DAPT）与不良转归高风险具有相关性；在1～12个月中断DAPT则与支架血栓形成（ST）和不良心血管转归低发生率有相关性。论文2月7日在线发表于《欧洲心脏杂志》（Eur Heart J）。【原文下载】

此项研究共纳入4896例接受R-ZES置入的心梗患者，并评估DAPT中断与支架血栓形成（ST）和心源性死亡/靶血管心梗（CD/TVMI）的相关性。以阿司匹林和/或噻吩并吡啶中断>1天定义DAPT中断，以中断>14天定义长期中断。以无中断、支架置入1个月内中断和>1～12个月中断DAPT将患者分为三组。

结果显示，DAPT中断和无中断患者分别为1069例（21.83%）和3827例。在166例1个月内中断组患者中共出现6例确定性/可疑ST事件（3.61%），在>1～12个月中断组患者中共出现1例ST事件（0.11%）。在无中断患者中共出现32例ST事件（0.84%）。在1个月内和>1～12个月中断组患者中CD/TVMI发生率分别为6.84%和1.41%，在无中断患者中则为4.08%。

原始出处：

版权声明：
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料，版权均属于梅斯医学所有。非经授权，任何媒体、网站或个人不得转载，授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章，或“梅斯号”自媒体发布的文章，仅系出于传递更多信息之目的，本站仅负责审核内容合规，其内容不代表本站立场，本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系，我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1793174, encodeId=5dca1e9317457, content=<a href='/topic/show?id=29aa150423e' target=_blank style='color:#2F92EE;'>#R-ZES置入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15042, encryptionId=29aa150423e, topicName=R-ZES置入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Apr 10 15:07:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861973, encodeId=877e18619e3ef, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Mar 11 20:07:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355829, encodeId=33e2135582998, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374329, encodeId=07aa13e43292d, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5691, encryptionId=6d5d56912e, topicName=DAPT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562209, encodeId=57e715622093a, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=)]
    2014-04-10 1249884fm87暂无昵称

    #R-ZES置入#

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1793174, encodeId=5dca1e9317457, content=<a href='/topic/show?id=29aa150423e' target=_blank style='color:#2F92EE;'>#R-ZES置入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15042, encryptionId=29aa150423e, topicName=R-ZES置入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Apr 10 15:07:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861973, encodeId=877e18619e3ef, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Mar 11 20:07:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355829, encodeId=33e2135582998, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374329, encodeId=07aa13e43292d, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5691, encryptionId=6d5d56912e, topicName=DAPT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562209, encodeId=57e715622093a, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=)]
    2014-03-11 docwu2019

    #高风险#

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1793174, encodeId=5dca1e9317457, content=<a href='/topic/show?id=29aa150423e' target=_blank style='color:#2F92EE;'>#R-ZES置入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15042, encryptionId=29aa150423e, topicName=R-ZES置入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Apr 10 15:07:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861973, encodeId=877e18619e3ef, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Mar 11 20:07:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355829, encodeId=33e2135582998, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374329, encodeId=07aa13e43292d, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5691, encryptionId=6d5d56912e, topicName=DAPT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562209, encodeId=57e715622093a, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=)]
    2014-02-21 zhaojie88

    #ART#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1793174, encodeId=5dca1e9317457, content=<a href='/topic/show?id=29aa150423e' target=_blank style='color:#2F92EE;'>#R-ZES置入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15042, encryptionId=29aa150423e, topicName=R-ZES置入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Apr 10 15:07:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861973, encodeId=877e18619e3ef, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Mar 11 20:07:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355829, encodeId=33e2135582998, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374329, encodeId=07aa13e43292d, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5691, encryptionId=6d5d56912e, topicName=DAPT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562209, encodeId=57e715622093a, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=)]
    2014-02-21 mnda

    #DAPT#

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1793174, encodeId=5dca1e9317457, content=<a href='/topic/show?id=29aa150423e' target=_blank style='color:#2F92EE;'>#R-ZES置入#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=15042, encryptionId=29aa150423e, topicName=R-ZES置入)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf1d2500084, createdName=1249884fm87暂无昵称, createdTime=Thu Apr 10 15:07:00 CST 2014, time=2014-04-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1861973, encodeId=877e18619e3ef, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=102813, encryptionId=a374102813a1, topicName=高风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Tue Mar 11 20:07:00 CST 2014, time=2014-03-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1355829, encodeId=33e2135582998, content=<a href='/topic/show?id=b0702e84b9' target=_blank style='color:#2F92EE;'>#ART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2784, encryptionId=b0702e84b9, topicName=ART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1374329, encodeId=07aa13e43292d, content=<a href='/topic/show?id=6d5d56912e' target=_blank style='color:#2F92EE;'>#DAPT#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5691, encryptionId=6d5d56912e, topicName=DAPT)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6a8d381, createdName=mnda, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1562209, encodeId=57e715622093a, content=<a href='/topic/show?id=f69d864413' target=_blank style='color:#2F92EE;'>#HEART#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=8644, encryptionId=f69d864413, topicName=HEART)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=395f25, createdName=爆笑小医, createdTime=Fri Feb 21 05:07:00 CST 2014, time=2014-02-21, status=1, ipAttribution=)]
    2014-02-21 爆笑小医

    #HEART#

    0